Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Discovery & Translation

Science Spotlight: Reducing HIV load, new glycopeptide antibiotics, and more

BioCentury’s roundup of translational innovations

August 14, 2024 8:34 PM UTC

A group led by Leor Weinberger at University of California San Francisco developed a strategy to reduce HIV load in patients, and suggested the method may open an avenue to a “functional cure.”

The Science paper authors developed HIV therapeutic interfering particles (TIPs), engineered from portions of the HIV genome that contain deletions that suppress HIV replication. After administration, virions that incorporate the TIPS become non-pathogenic...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article